Loading clinical trials...
Loading clinical trials...
A Phase I, Open Label, Parallel Group, Multi-center Single Dose Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36
Conditions
Interventions
NOX-E36
Locations
2
Hungary
DRC
Balatonfüred, Hungary
Innophar Mo S.R.L.
Chisinau, Moldova
Start Date
June 1, 2011
Primary Completion Date
October 1, 2012
Completion Date
October 1, 2012
Last Updated
October 19, 2012
NCT07154901
NCT07165015
NCT06352411
NCT07445906
NCT06661733
NCT07124403
Lead Sponsor
TME Pharma AG
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions